Modified Folfox6 as Adjuvant Chemotherapy in Vietnamese Patients With Colorectal Cancer

Colorectal cancer is the third most common cancer and the second leading cause of death from cancer worldwide. In Vietnam, the disease is the fifth leading cancer (8.9%), with 14 733 new cases in 2018. In recent years, the mFolfox6 regimen has been indicated commonly as the adjuvant chemotherapy aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, T. Quang, Bui, T. Oanh, Tran, P. Thao, Tran, V. Thuan, Nguyen, V. Hieu, Chu, Q. Hoan, Bui, T. A. Tuyet, Le, N. Quynh, Le, V. Quang, Dao, V. Tu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Special Collection on Cancers in Vietnam: Burden and Control Efforts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640065/
https://www.ncbi.nlm.nih.gov/pubmed/31317770
http://dx.doi.org/10.1177/1073274819864111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640065/
https://www.ncbi.nlm.nih.gov/pubmed/31317770
http://dx.doi.org/10.1177/1073274819864111

Ejemplares similares